Evidence map›Paper›PMID 39239731›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Genomic analysis of

Caroline Rouard, David R Greig, Thamida Tauhid, Susann Dupke, Elisabeth Njamkepo, Ettore Amato, Boas van der Putten, Umaer Naseer, Marion Blaschitz, Georgia D Mandilara and 12 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Public health surveillance ofJournal of medical microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cholera due to exposure in Europe associated with consumption of holy water from Ethiopia, January to February 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Caroline RouardInstitut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France.
David R GreigGastrointestinal Bacteria Reference Unit (GBRU), UK Health Security Agency, London, United Kingdom.
Thamida TauhidPublic Health Agency of Sweden, Unit for Laboratory Surveillance of Bacterial Pathogens, Solna, Sweden.
Susann DupkeCentre for Biological Threats and Special Pathogens (ZBS 2), National Consultant Laboratory for Human Pathogenic Vibrio species, Robert Koch Institute, Berlin, Germany.
Elisabeth NjamkepoInstitut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France.
Ettore AmatoNorwegian Institute of Public Health, Department of Infection Control and Preparedness, Oslo, Norway.
Boas van der PuttenCentre for Infectious Disease Control, Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Umaer NaseerNorwegian Institute of Public Health, Department of Infection Control and Preparedness, Oslo, Norway.
Marion BlaschitzAustrian Agency for Health and Food Safety, Vienna, Austria.
Georgia D MandilaraNational Reference Centre for Salmonella, School of Public Health, University of West Attica, Athens, Greece.
James Cohen StuartDepartment of Medical Microbiology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Alexander IndraParacelsus Medical University of Salzburg, Salzburg, Austria.
Harold NoëlSanté publique France, Saint Maurice, France.
Theologia SideroglouDirectorate of Epidemiological Surveillance and Intervention for Infectious Diseases, National Public Health Organization (NPHO), Athens, Greece.
Florian HegerAustrian Agency for Health and Food Safety, Vienna, Austria.
Maaike van den BeldCentre for Infectious Disease Control, Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Astrid Louise WesterNorwegian Institute of Public Health, Department of Bacteriology, Norwegian Reference Laboratory for Cholera, Oslo, Norway.
Marie-Laure QuiliciInstitut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France.
Holger C ScholzCentre for Biological Threats and Special Pathogens (ZBS 2), National Consultant Laboratory for Human Pathogenic Vibrio species, Robert Koch Institute, Berlin, Germany.
Inga FrödingPublic Health Agency of Sweden, Unit for Laboratory Surveillance of Bacterial Pathogens, Solna, Sweden.
Claire JenkinsGastrointestinal Bacteria Reference Unit (GBRU), UK Health Security Agency, London, United Kingdom.
François-Xavier WeillInstitut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Vibrions et du choléra, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundThe number of cholera cases reported to the World Health Organization (WHO) in 2022 was more than double that of 2021. Nine countries of the WHO European Region reported 51 cases of cholera in 2022 vs five reported cases in 2021.AimWe aimed to confirm that the

Indexed as

Anti-Bacterial AgentsCholeraPhylogenyVibrio cholerae O1Drug Resistance, BacterialEuropeGenome, BacterialGenomicsHumansMicrobial Sensitivity TestsVirulenceWhole Genome SequencingAnti-Bacterial Agents2022CholeraEuropemicrobial genomicssurveillanceVibrio choleraewhole-genome sequencing

Identifiers

PMID39239731
PMCPMC11378513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.